The Patent Finder

Pangu Biopharma Limited

10 patents currently held · Updated Nov 20, 2026
52 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

6
Ending by 2030
Mar 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 12, 2027
    The maintenance fee for Histidyl-Trna Synthetase-Fc Conjugates (US 10,472,618) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
  • 1 fee due Jul 7, 2027
    The maintenance fee for Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities (US 10,526,419) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,753,638Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities
In force
 · High confidence
In forceHigh confidence
US 9,605,265Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities
In force
 · High confidence
In forceHigh confidence
US 10,017,582Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities
In force
 · High confidence
In forceHigh confidence
US 10,526,419Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities
In force
 · High confidence
In forceHigh confidence
US 10,941,214Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities
In force
 · High confidence
In forceHigh confidence
US 11,078,299Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities
In force
 · High confidence
In forceHigh confidence
US 8,969,301Innovative Discovery of Therapeutic, Diagnostic, and Antibody Compositions Related to Protein Fragments of Aspartyl-Trna Synthetases
In force
 · High confidence
In forceHigh confidence
US 9,422,539Innovative Discovery of Therapeutic, Diagnostic, and Antibody Compositions Related to Protein Fragments of Histidyl-Trna Synthetases
In force
 · Medium confidence
In forceMedium confidence
US 12,497,466Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities
In force
 · High confidence
In forceHigh confidence
US 10,472,618Histidyl-Trna Synthetase-Fc Conjugates
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 52 patents in force now held by others · 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

17 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited